BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

AIMS Neuroscience is an esteemed open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to advancing the field of neuroscience since its inception in 2014. With a robust ISSN of 2373-8006 and an E-ISSN of 2373-7972, this journal aims to provide a platform for innovative research and scholarly discourse that spans the diverse and dynamic landscape of the neuroscience discipline. As of 2023, it holds a respectable Q3 category ranking in the miscellaneous neuroscience field and ranks #65 out of 113 in general neuroscience according to Scopus, positioning it in the 42nd percentile for impact. AIMS Neuroscience encompasses a broad scope of topics, from neurobiology and cognitive neuroscience to computational models and neuroengineering, making it a vital resource for researchers, professionals, and students alike. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and knowledge sharing within the global neuroscience community.

Aging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.

EXPERIMENTAL AGING RESEARCH, published by Taylor & Francis Inc., is a leading journal that has been at the forefront of aging research since its inception in 1975. With an ISSN of 0361-073X and an E-ISSN of 1096-4657, this journal has earned a notable reputation, including a Q3 ranking in the field of Aging and impressive Q1 and Q2 rankings in Arts and Humanities and Geriatrics and Gerontology respectively. This positions the journal within the top percentile of its category, highlighting its significant impact and contribution to the scientific community. Covering a broad scope that intersects various disciplines, EXPERIMENTAL AGING RESEARCH aims to disseminate pioneering research, foster interdisciplinary collaboration, and provide a platform for innovative studies that enhance understanding of the aging process. While it currently does not offer Open Access, researchers and academics can access its rich repository of knowledge that spans multiple facets of aging, from physiological changes to psychological impacts. As the field of aging continues to evolve, this journal remains an essential resource for researchers, professionals, and students dedicated to advancing knowledge and practices concerning aging and longevity.

Aging Clinical and Experimental Research, published by Springer, is a premier journal dedicated to advancing the field of geriatric medicine and understanding the complexities of aging. With a commitment to publishing high-quality original research, review articles, and clinical studies, this journal plays a crucial role in disseminating knowledge to researchers, healthcare professionals, and students interested in the biological, clinical, and social aspects of aging. Boasting a 2023 impact factor that places it in the Q2 quartile for both Aging and Geriatrics and Gerontology categories, it ranks favorably within the Scopus metrics—20th out of 116 in Geriatrics and Gerontology and 15th out of 38 in Aging. The journal provides vital insights for the ongoing discourse in aging research, making it an essential resource for those seeking to enhance their understanding of aging-related phenomena and improve healthcare outcomes across populations. The converged years of publication from 1989 to 2024 demonstrate its longstanding commitment to the field, highlighted by its notable presence in Germany and access to a broad international readership.

Aging Medicine and Healthcare is a leading Open Access journal dedicated to advancing the understanding of geriatric health and the complexities of aging. Published by the Asia Pacific League Clinical Gerontology & Geriatrics, this innovative journal began its journey in 2019 and has since established itself as an important resource for healthcare professionals, researchers, and students interested in the fields of geriatrics and gerontology. With an impact factor that reflects its growing significance (ranked in the 21st percentile within its category), the journal aims to disseminate high-quality research and practical insights that can inform clinical practice and enhance patient care for aging populations. As an Open Access publication, it ensures that research findings are freely accessible, fostering collaboration and knowledge sharing among academics and practitioners globally. The journal is poised to be a vital platform for innovative studies, systematic reviews, and case reports that illuminate the challenges and opportunities in aging medicine.

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

Frontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.

AGING NEUROPSYCHOLOGY AND COGNITION, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading scholarly journal that spans the interdisciplinary fields of psychology, neuropsychology, and gerontology. With a strong focus on understanding aging processes and cognitive function, this journal serves as a critical platform for researchers, clinicians, and students dedicated to advancing knowledge in the realm of cognitive aging. The journal, established in 1994, presents high-quality research articles, comprehensive reviews, and innovative studies that contribute to the discourse surrounding mental health and aging. Notably, it has been recognized with a 2023 Q2 ranking in Experimental and Cognitive Psychology and Neuropsychology categories, reflecting its significant impact within these domains. The journal includes open access options, making it widely accessible to a global audience. Researchers interested in the latest findings and theoretical developments in aging neuropsychology will find this journal an invaluable resource, further enhanced by its robust Scopus rankings and commitment to academic excellence through 2024 and beyond.

AGEING RESEARCH REVIEWS, published by Elsevier Ireland Ltd, is a prestigious academic journal dedicated to advancing our understanding of the biological, psychological, and societal aspects of aging. With an ISSN of 1568-1637 and E-ISSN of 1872-9649, this journal has established itself as a leading resource in the fields of Aging, Biochemistry, Biotechnology, Molecular Biology, and Neurology, consistently ranked in the Q1 category across these disciplines as of 2023. For researchers, students, and professionals eager to explore cutting-edge findings and innovative methodologies, AGEING RESEARCH REVIEWS gathers comprehensive reviews that facilitate a deeper understanding of age-related processes. Its high impact factor and exceptional Scopus rankings—ranking #1 in Aging and #3 in Neurology—underscore its critical role in shaping contemporary aging research. This journal not only serves as a vital reference point but also fosters a collaborative space for the scientific community focused on improving health outcomes across the life span. Published continuously since 2002 and with a converging focus through 2024, AGEING RESEARCH REVIEWS remains committed to disseminating impactful knowledge that drives progress in our understanding of the aging process.